Anavex Life Sciences Corp - ESG Rating & Company Profile powered by AI
This Disclosure score includes seventeen United Nations SDGs including: 'Gender Equality', 'Responsible Production & Consumption' and 'Peace, Justice & Strong Institutions'. Full Sustainability analysis of Anavex Life Sciences Corp are accessed by signing up for free. If you are employed by Anavex Life Sciences Corp and you wish to use your ESG rating, please get in touch.
Anavex Life Sciences Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 1.6, social score of 4.8 and governance score of 5.3.
4.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1376 | Vericel Corp | 4.2 | High |
| 1376 | vTv Therapeutics Inc | 4.2 | High |
| 1412 | Anavex Life Sciences Corp | 4.1 | High |
| 1412 | Abivax SA | 4.1 | High |
| 1412 | Aeglea Bio Therapeutics Inc | 4.1 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Anavex Life Sciences Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Anavex Life Sciences Corp report the average age of the workforce?
Sign up for free to unlockDoes Anavex Life Sciences Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Anavex Life Sciences Corp offer flexible work?
Sign up for free to unlockDoes Anavex Life Sciences Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Anavex Life Sciences Corp conduct supply chain audits?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Anavex Life Sciences Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose water use targets?
Sign up for free to unlockDoes Anavex Life Sciences Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Anavex Life Sciences Corp have a product recall in the last two years?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Anavex Life Sciences Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Anavex Life Sciences Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose parental leave metrics?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Anavex Life Sciences Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Anavex Life Sciences Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Anavex Life Sciences Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose its waste policy?
Sign up for free to unlockDoes Anavex Life Sciences Corp report according to TCFD requirements?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose energy use targets?
Sign up for free to unlockDoes Anavex Life Sciences Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Anavex Life Sciences Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Anavex Life Sciences Corp
These potential risks are based on the size, segment and geographies of the company.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.